Cargando…
Biomarkers in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma
Since the early 1970s, a dramatic change has occurred in the epidemiology of esophageal malignancy in both North America and Europe: the incidence of adenocarcinomas of the lower esophagus and esophagogastric junction is increasing. Several lifestyle factors are implicated in this change, including...
Autores principales: | Williams, L.J., Guernsey, D.L., Casson, A.G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Multimed Inc.
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1891165/ https://www.ncbi.nlm.nih.gov/pubmed/17576439 |
Ejemplares similares
-
Signaling Pathways in the Pathogenesis of Barrett’s Esophagus and Esophageal Adenocarcinoma
por: Maslenkina, Ksenia, et al.
Publicado: (2023) -
Chemoprevention in Barrett’s esophagus and esophageal
adenocarcinoma
por: Alkhayyat, Motasem, et al.
Publicado: (2021) -
Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma
por: Lv, Jing, et al.
Publicado: (2019) -
Identification of potential biomarkers in Barrett’s esophagus derived esophageal adenocarcinoma
por: Yi, Nan, et al.
Publicado: (2023) -
Immune determinants of Barrett’s progression to esophageal adenocarcinoma
por: Lagisetty, Kiran H., et al.
Publicado: (2021)